In vitro activity of penem-1 in combination with β-lactams against blaKPC-possessing Klebsiella pneumoniae isolates

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 4, 2010, Pages 1650-1651

  Endimiani, Andrea ^a   Bethel, Christopher ^b   Choudhary, Yuvraj ^b   Bonomo, Robert A ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; PENEM 1; PIPERACILLIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; ENZYME INHIBITORS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 77950126637     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01821-09     Document Type: Letter

References (10)

1. Bethel, C. R., A. M. Distler, M. W. Ruszczycky, M. P. Carey, P. R. Carey, A. M. Hujer, M. Taracila, M. S. Helfand, J. M. Thomson, M. Kalp, V. E. Anderson, D. A. Leonard, K. M. Hujer, T. Abe, A. M. Venkatesan, T. S. Mansour, and R. A. Bonomo. 2008. Inhibition of OXA-1 β-lactamase by penems. Antimicrob. Agents Chemother. 52:3135-3143.
2. CLSI. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
3. CLSI. 2010. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
4. KPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J. Antimicrob. Chemother. 64:1102-1110.
5. KPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J. Antimicrob. Chemother. 63:427-437.
6. KPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob. Agents Chemother. 54:526-529.
7. Lee, J., G. Patel, S. Huprikar, D. P. Calfee, and S. G. Jenkins. 2009. Decreased susceptibility to polymyxin B during treatment for carbapenemresistant Klebsiella pneumoniae infection. J. Clin. Microbiol. 47:1611-1612.
8. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
9. Papp-Wallace, K. M., C. R. Bethel, A. M. Distler, C. Kasuboski, M. Taracila, and R. A. Bonomo. 2010. Inhibitor resistance in the KPC-2 β-lactamase: a preeminent property of this class A β-lactamase. Antimicrob. Agents Chemother. 54:890-897.
10. Weiss, W. J., P. J. Petersen, T. M. Murphy, L. Tardio, Y. Yang, P. A. Bradford, A. M. Venkatesan, T. Abe, T. Isoda, A. Mihira, H. Ushirogochi, T. Takasake, S. Projan, J. O'Connell, and T. S. Mansour. 2004. In vitro and in vivo activities of novel 6-methylidene penems as β-lactamase inhibitors. Antimicrob. Agents Chemother. 48:4589-4596.